Results 331 to 340 of about 198,722 (342)

Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling

Cancer Cell, 2015
Eishu Hirata, Amaya Viros, Michiyuki Matsuda   +2 more
exaly  

Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations

Oncogene, 2018
M. Dankner, A. Rose, Shivshankari Rajkumar, P. Siegel, I. Watson   +4 more
semanticscholar   +1 more source

Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF

Cell, 2010
Steven R Whittaker, Nathalie Dhomen, Richard Marais   +2 more
exaly  

Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling

Cancer Cell, 2014
Jawahar Sudhamsu, Wendy N Sandoval, Wilson Phung   +2 more
exaly  

Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients

Nature Medicine, 2019
R. Sullivan, O. Hamid, R. Gonzalez, J. Infante, Manish R. Patel, F. Hodi, Karl D. Lewis, H. Tawbi, G. Hernandez, M. Wongchenko, Y. Chang, L. Roberts, M. Ballinger, Yibing Yan, E. Cha, P. Hwu   +15 more
semanticscholar   +1 more source

Vemurafenib: the first drug approved for BRAF-mutant cancer

Nature Reviews Drug Discovery, 2012
exaly  

Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF

Cancer Cell, 2013
Rizwan Haq, Glenn C Rowe, Abhinav Nellore   +2 more
exaly  

Hochgebohrner Braf

2000
openaire   +1 more source

BRaf-Signaling

2017
openaire   +1 more source

BRAF Mutations

2016
openaire   +1 more source